Mercadal Santiago, Cortés-Romera Montserrat, Vélez Patricia, Climent Fina, Gámez Cristina, González-Barca Eva
Servicio de Hematología, Institut Català d'Oncologia, Hospital Duran i Reynals, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, España.
Unidad PET-TC, Institut de Diagnòstic per la Imatge (IDI), Hospital Universitario de Bellvitge, L'Hospitalet del Llobregat, Barcelona, España.
Med Clin (Barc). 2015 Jun 8;144(11):503-6. doi: 10.1016/j.medcli.2014.09.010. Epub 2014 Nov 26.
To evaluate the role of positron emission tomography combined with computed tomography (PET-CT) in the initial evaluation and response assessment in primary central nervous system lymphoma (PCNSL).
Fourteen patients (8 males) with a median age 59.5 years diagnosed of PCNSL. A brain PET-CT and magnetic resonance imaging (MRI) were performed in the initial evaluation. In 7 patients a PET-CT after treatment was performed.
PET-CT showed at diagnosis 31 hypermetabolic focuses and MRI showed 47 lesions, with a good grade of concordance between both (k = 0.61; P = .005). In the response assessment, correlation between both techniques was good, and PET-CT was helpful in the appreciation of residual MRI lesions. Overall survival at 2 years of negative vs. positive PET-CT at the end of treatment was 100 vs. 37.5%, respectively (P = .045).
PET-CT can be useful in the initial evaluation of PCNSL, and especially in the assessment of response. Despite the fact that PET-CT detects less small lesions than MRI, a good correlation between MRI and PET-CT was observed. It is effective in the evaluation of residual lesions. Prospective studies are needed to confirm their possible prognostic value.
评估正电子发射断层扫描联合计算机断层扫描(PET-CT)在原发性中枢神经系统淋巴瘤(PCNSL)初始评估及疗效评估中的作用。
14例患者(8例男性)被诊断为PCNSL,中位年龄59.5岁。初始评估时进行脑部PET-CT及磁共振成像(MRI)检查。7例患者在治疗后进行了PET-CT检查。
诊断时PET-CT显示31个高代谢灶,MRI显示47个病灶,两者之间具有良好的一致性(k = 0.61;P = 0.005)。在疗效评估中,两种技术之间的相关性良好,PET-CT有助于识别残留的MRI病灶。治疗结束时PET-CT阴性与阳性患者的2年总生存率分别为100%和37.5%(P = 0.045)。
PET-CT在PCNSL的初始评估中可能有用,尤其是在疗效评估方面。尽管PET-CT检测到的小病灶比MRI少,但MRI与PET-CT之间观察到良好的相关性。它在评估残留病灶方面有效。需要进行前瞻性研究以证实其可能的预后价值。